NLS Global report

AstraZeneca and Bristol Myers Squibb have held preliminary discussions about a possible merger that would create one of the world’s largest pharmaceutical groups, with a combined value of nearly USD 400 billion, according to reports citing people familiar with the matter (source: Reuters).

Johnson & Johnson has entered a strategic collaboration with Sail Biomedicines to advance in vivo CAR-T therapies for immune-mediated diseases.

FedEx has announced the launch of FedEx Life Sciences, a dedicated organization created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments.

The offer values PolyPeptide's equity at approximately CHF 1.46 billion.

Merck and Bio-Techne Corporation have entered into a definitive agreement pursuant to which Merck will, subject to customary closing conditions, acquire Bio-Techne for USD 73 per share in cash, representing a total enterprise value of approximately USD 11.3 billion, a 36% premium to Bio-Techne’s one-month volume weighted average trading price.

After more than four years of full-scale war waged by Russia in Ukraine, Ukrainians’ physical and mental health – and the entire healthcare system – are under extreme pressure. Today, relief efforts focus on knowledge transfer, new ways of managing and operating healthcare, and long-term partnerships, while also drawing lessons from Ukraine’s own resilience, crisis responses, and rehabilitation solutions.